Verastem, Inc. Accumulated Other Comprehensive Income
Verastem, Inc. (VSTM) had Accumulated Other Comprehensive Income of $8.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.04M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.62M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.23M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.54M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $8.04M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $8.62M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $5.23M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.54M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $5.29M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.64M 10-Q · filed 2025-05-13 |
| 2024-03-31 | -$4.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $13.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $49.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $6.00K 10-Q · filed 2023-05-09 |
| 2022-09-30 | -$39.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$130.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$113.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $34.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $27.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $39.00K 10-Q · filed 2021-08-02 |
| 2021-03-31 | $34.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $53.00K 10-K · filed 2022-03-28 |
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $14.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $27.00K 10-Q · filed 2019-10-30 |
| 2019-06-30 | $86.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $110.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $127.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $2.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $4.00K 10-Q · filed 2018-08-08 |
| 2017-12-31 | -$2.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $2.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$5.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $12.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $29.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $60.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $77.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $135.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $43.00K 10-K · filed 2017-03-23 |
| 2015-09-30 | $44.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $32.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $39.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $11.00K 10-K · filed 2016-03-03 |
| 2014-09-30 | $26.00K 10-Q · filed 2014-10-30 |
| 2014-06-30 | $29.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $22.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $28.00K 10-K · filed 2015-03-10 |
| 2013-09-30 | $80.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$3.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $18.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $22.00K 10-K · filed 2014-03-06 |
| 2012-09-30 | $22.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | -$11.00K 10-Q · filed 2012-08-13 |
| 2012-03-31 | -$45.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | -$2.00K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |